| Year |
Citation |
Score |
| 2017 |
Pollard RE, Watson KD, Hu X, Ingham E, Ferrara KW. Feasibility of quantitative contrast ultrasound imaging of bladder tumors in dogs. The Canadian Veterinary Journal = La Revue Veterinaire Canadienne. 58: 70-72. PMID 28042158 |
0.533 |
|
| 2013 |
Hu X, Caskey CF, Mahakian LM, Kruse DE, Beegle JR, Declèves AE, Rychak JJ, Sutcliffe PL, Sharma K, Ferrara KW. In vivo validation and 3D visualization of broadband ultrasound molecular imaging. American Journal of Nuclear Medicine and Molecular Imaging. 3: 336-49. PMID 23901359 |
0.708 |
|
| 2013 |
Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu JY, Stephen Lee KS, Wettersten HI, Ulu A, Hu X, Tam S, Hwang SH, Ingham ES, Kieran MW, Weiss RH, Ferrara KW, et al. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proceedings of the National Academy of Sciences of the United States of America. 110: 6530-5. PMID 23553837 DOI: 10.1073/Pnas.1304321110 |
0.479 |
|
| 2012 |
Hu X, Kheirolomoom A, Mahakian LM, Beegle JR, Kruse DE, Lam KS, Ferrara KW. Insonation of targeted microbubbles produces regions of reduced blood flow within tumor vasculature. Investigative Radiology. 47: 398-405. PMID 22659591 DOI: 10.1097/Rli.0B013E31824Bd237 |
0.589 |
|
| 2011 |
Caskey CF, Hu X, Ferrara KW. Leveraging the power of ultrasound for therapeutic design and optimization. Journal of Controlled Release : Official Journal of the Controlled Release Society. 156: 297-306. PMID 21835212 DOI: 10.1016/J.Jconrel.2011.07.032 |
0.698 |
|
| 2011 |
Watson KD, Hu X, Lai CY, Lindfors HA, Hu-Lowe DD, Tuthill TA, Shalinsky DR, Ferrara KW. Novel ultrasound and DCE-MRI analyses after antiangiogenic treatment with a selective VEGF receptor inhibitor. Ultrasound in Medicine & Biology. 37: 909-21. PMID 21531499 DOI: 10.1016/J.Ultrasmedbio.2011.03.001 |
0.677 |
|
| 2011 |
Anderson CR, Hu X, Zhang H, Tlaxca J, Declèves AE, Houghtaling R, Sharma K, Lawrence M, Ferrara KW, Rychak JJ. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Investigative Radiology. 46: 215-24. PMID 21343825 DOI: 10.1097/Rli.0B013E3182034Fed |
0.62 |
|
| 2011 |
Hu X, Mahakian L, Caskey C, Beegle J, Kruse D, Rychak J, Sutcliffe P, Ferrara K. A fast ultrasound molecular imaging method and its 3D visualization in vivo Ieee International Ultrasonics Symposium, Ius. 1618-1621. DOI: 10.1109/ULTSYM.2011.0402 |
0.613 |
|
| 2011 |
Hu X, Kheirolomoom A, Mahakian LM, Beegle JR, Ingham ES, Caskey CF, Kruse DE, Ferrara KW. Reduced blood flow in murine tumors after the destruction of bound, targeted microbubbles Ieee International Ultrasonics Symposium, Ius. 955-958. DOI: 10.1109/ULTSYM.2011.0234 |
0.672 |
|
| 2010 |
Hu X, Zheng H, Kruse DE, Sutcliffe P, Stephens DN, Ferrara KW. A sensitive TLRH targeted imaging technique for ultrasonic molecular imaging. Ieee Transactions On Ultrasonics, Ferroelectrics, and Frequency Control. 57: 305-16. PMID 20178897 DOI: 10.1109/Tuffc.2010.1411 |
0.617 |
|
| 2010 |
Gu X, Zhong H, Wan M, Hu X, Lv D, Shen L, Zhang X. Parametric perfusion imaging based on low-cost ultrasound platform. Ultrasound in Medicine & Biology. 36: 130-44. PMID 19931972 DOI: 10.1016/J.Ultrasmedbio.2009.09.002 |
0.479 |
|
| 2010 |
Caskey CF, Qin S, Hu X, Kheirolomoom A, Ferrara KW. Experimental and theoretical studies of microbubble interaction with tissue help optimize drug delivery and imaging. The Journal of the Acoustical Society of America. 128: 2439-2439. DOI: 10.1121/1.3508717 |
0.681 |
|
| 2009 |
Pollard RE, Dayton PA, Watson KD, Hu X, Guracar IM, Ferrara KW. Motion corrected cadence CPS ultrasound for quantifying response to vasoactive drugs in a rat kidney model. Urology. 74: 675-81. PMID 19589583 DOI: 10.1016/J.Urology.2009.01.086 |
0.532 |
|
| 2009 |
Ferrara K, Hu X, Zhang H, Stephens D, Kruse D. WE-D-210A-03: Systems and Probes for Ultrasound Molecular Imaging Medical Physics. 36: 2780-2780. DOI: 10.1118/1.3182548 |
0.574 |
|
| Show low-probability matches. |